Brain cancer relapse prediction has become a critical focus in pediatric oncology, particularly in improving outcomes for young patients battling the complexities of gliomas.Recent advancements, notably the application of AI in cancer care, have significantly enhanced our understanding of relapse risks associated with pediatric brain tumors.